AKT1 and lung carcinoma: The KEGG pathway enrichment analysis suggested that the common targets included four vital cancer-associated pathways, namely, the PI3K/Akt, MAPK, PD-1 checkpoint, and PD-L1 expression pathways, which might be vital for baicalein in the treatment of lung carcinomas.